Compositions of NDV and methods of use thereof for treatment of cancer
US7615209B2 · kind B2 · utility
1Cited by
10References
33Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 20, 2006 |
| Grant date | Nov 10, 2009 |
| Priority date | — |
| Expiry date | Apr 9, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/18132
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses methods for inducing regression of a tumor in a subject by administering a pharmaceutical composition comprising a lentogenic strain of Newcastle disease virus (NDV). A preferred viral strain of NDV for inducing regression of a tumor in a subject is a clonal strain of NDV, the NDV HUJ. The methods of the present invention are particularly useful for inducing regression of tumors in patients unresponsive to conventional anti-cancer therapies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.